As we head into the height of flu season, Reuters is reporting there is a shortage of Tamiflu.
“There has been strong and early demand for Tamiflu Oral Suspension (OS) and we are experiencing a temporary delay in the packaging of Tamiflu OS,” said Tara Iannuccillo, a spokeswoman for Roche Holding AG’s Genentech unit which manufactures the drug and uses distributors to supply retail pharmacies with the product.
“A brief shortage of OS is expected through mid-January. We may be unable to fill complete orders from distributors for a limited time,” Iannuccillo added.
Tamiflu is used to reduce the severity of the flu when taken at the outset of symptoms. The oral suspension of the drug is primarily prescribed for children under the age of 13 and for people who have difficulty swallowing.
Read more here.
